Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Gov. Ron DeSantis speaks during a press conference about the opening of a COVID-19 vaccination site at the Hard Rock Stadium in Miami Gardens. Photo: Joe Raedle/Getty Images

After a solid year of living with a pandemic, the national press is beginning to ask the question that even Democrats have been quietly pondering in the Sunshine State: Was Gov. Ron DeSantis' pandemic response right for Florida?

Don't forget: More than 32,000 Floridians have died, a number the state's leaders rarely acknowledge, but our death rate is no worse than the national average — and better than some states with tighter restrictions.

The Los Angeles Times compared Florida and California's responses:

  • "California imposed myriad restrictions that battered the economy, and have left most public school students learning at home for a year. ... Florida adopted a more laissez-faire approach decried by public health experts — allowing indoor restaurant dining, leaving masks optional and getting children back in classrooms sooner."
  • But, it points out, "If California had Florida’s death rate, roughly 6,000 more Californians would be dead from COVID-19, and tens of thousands of additional patients likely would have landed in already overburdened hospitals. And if Florida had California’s death rate, roughly 3,000 fewer Floridians would be dead from COVID-19."

On Sunday's front page, the New York Times explored the positives — from the booming real-estate market to Florida's low unemployment rate — of an early reopening: "Much of the state has a boomtown feel," writes Patricia Mazzei, "a sense of making up for months of lost time."

  • The Times notes that Florida's unemployment rate is 5.1%, compared to 9.3% in California, 8.7% in New York and 6.9% in Texas.
  • "That debate about reopening schools? It came and went months ago. Children have been in classrooms since the fall."

The big picture: Much of the public part of DeSantis' pandemic response feels more and more like an audition for a 2024 presidential run, which Politico's Marc Caputo has noted.

  • "With a COVID death count cover-up consuming New York Gov. Andrew Cuomo and a pandemic-related recall effort haunting California Gov. Gavin Newsom, Republicans are embracing DeSantis as a red-state exemplar."

Our thought bubble: We've long known that the state's pro-business Republican leadership was making a sort of grand bargain: that the death toll was the price paid for keeping commerce flowing and keeping kids in school.

  • The closer you are to either loss or to the fullness of life will likely determine how you feel about the state's response.

This story first appeared in the Axios Tampa Bay newsletter, designed to help readers get smarter, faster on the most consequential news unfolding in their own backyard.

Not a valid email format.
Not a valid email format.
Server error. Please try a different email.
Not a valid email format.
Not a valid email format.
Server error. Please try a different email.
Not a valid email format.
Not a valid email format.
Server error. Please try a different email.
Not a valid email format.
Not a valid email format.
Server error. Please try a different email.
Not a valid email format.
Not a valid email format.
Server error. Please try a different email.

Go deeper

Dan Primack, author of Pro Rata
16 mins ago - Economy & Business

IPO market holds firm amid stock market tumult

Illustration: Aïda Amer/Axios

The IPO market is doing its best Alfred E. Neuman impression so far this week, refusing to entertain everyone else's worries.

The big picture: Both the Dow and S&P 500 fell nearly 2% yesterday, as investors tried to measure the fallout of Chinese construction giant Evergrande defaulting on its $300 billion in liabilities.

2 hours ago - World

Sudanese government says it put down coup attempt

Prime Minister Abdullah Hamdok (L) and Sovereign Council Chief Gen. Abdel Fattah al-Burhan. Photo: Ashraf Shazly/AFP via Getty

The Sudanese government announced on Tuesday morning that its military and security services had foiled an attempted coup from within the country’s armed forces.

Why it matters: The apparent coup attempt comes with Sudan’s transitional government — in which power is shared between civilians and generals — facing crises on several fronts two years after dictator Omar al-Bashir was toppled in a popular uprising.

2 hours ago - Health

Johnson & Johnson says booster shot increases efficacy of COVID vaccine

Syringes and a vial of the Johnson and Johnson COVID-19 vaccine in French Polynesia on Sept. 8. Photo: Jerome Brouillet/AFP via Getty Images

Johnson & Johnson said in a press release Tuesday a global study showed that the protection offered by its coronavirus vaccine was strengthened by a booster shot.

Why it matters: While J&J has not formally applied for authorization to offer booster shots to the general public, it said it has shared the results of the study with the Food and Drug Administration and plans to share it with the World Health Organization and other health regulators.